These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 13462246)
1. [Action of 2-methyl-2-propyl-1,3-propanediol dicarbamate in rabbits; bioelectric & symptomatological aspects]. MONTANINI R; TERRANOVA R G Psichiatr Neuropatol; 1957; 85(2):401-11. PubMed ID: 13462246 [No Abstract] [Full Text] [Related]
2. [Effects of 2 methyl-2- (1 methyl propyl) 1-3 propanediol dicarbamate and (alpha bromo-alpha-ethyl butyryl) urea on glycemia of rabbits]. Sassine A; Rechencq E; Bourgeois JM J Physiol (Paris); 1969; 61 Suppl 2():400. PubMed ID: 4393692 [No Abstract] [Full Text] [Related]
3. Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system. HENDLEY CD; LYNES TE; BERGER FM Proc Soc Exp Biol Med; 1954 Dec; 87(3):608-10. PubMed ID: 13237321 [No Abstract] [Full Text] [Related]
4. [Pharmacological action of 2-methyl-2-propyl-1,3-propanediol dicarbamate. II. Antagonism with morphine]. SCARINCI V Boll Soc Ital Biol Sper; 1957 Jul; 33(7):1165-7. PubMed ID: 13510472 [No Abstract] [Full Text] [Related]
5. [Clinical use of a new drug with sedative action: 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate]. RIGOTTI S Minerva Med; 1956 Dec; 47(102):2178-81. PubMed ID: 13399941 [No Abstract] [Full Text] [Related]
10. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders]. IMBERCIADORI S; MANGANARO D Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942 [No Abstract] [Full Text] [Related]
11. [Effect of 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate) on the spinal electric potential in frogs]. RAPUZZI G; DOZIO G Arch Ital Sci Farmacol; 1958 Jan; 8(1):74-84. PubMed ID: 13522415 [No Abstract] [Full Text] [Related]
12. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate). MACCAGNANI G Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106 [No Abstract] [Full Text] [Related]
13. Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma). PHELPS WM Arch Pediatr (N Y); 1959 Jun; 76(6):243-50. PubMed ID: 13662106 [No Abstract] [Full Text] [Related]
15. Preliminary trial of a new muscle relaxant; nisopropyl-2-methyl-2-propyl-1,3 propanediol dicarbamate (soma) in outpatient children with cerebral palsy. SPEARS CE; PHELPS WM Arch Pediatr (N Y); 1959 Jul; 76(7):287-92. PubMed ID: 13662111 [No Abstract] [Full Text] [Related]
16. [Effect of novocaine on bioelectric activity of the cerebral cortex in rabbits]. BABICHEV VA Farmakol Toksikol; 1957; 20(6):70-1. PubMed ID: 13562145 [No Abstract] [Full Text] [Related]
17. Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine. Douglas JF; Kelley TF; Smith NB; Stockage JA Anal Chem; 1967 Jul; 39(8):956-8. PubMed ID: 6042638 [No Abstract] [Full Text] [Related]
18. [Action of chlorpromazine on bioelectric cerebral activity]. SUAREZ M; DOMINGUEZ J; TEIJEIRA J Rev Esp Pediatr; 1957; 13(73):1-23. PubMed ID: 13420912 [No Abstract] [Full Text] [Related]
19. [Early clinical experiments with 2-methyl-2-propyl-1,3-propandiol dicarbamate; new substance with sedative action]. BALDUINI M Farmaco Prat; 1956 Oct; 11(10):565-70. PubMed ID: 13414830 [No Abstract] [Full Text] [Related]
20. [Pharmacological actions of 2-methyl-2-n-propyl-1, 3-propandiol dicarbamate. I. Actions on experimental epilepsy]. SCARINCI V Arch Ital Sci Farmacol; 1957 Apr; 7(2):113-8. PubMed ID: 13459617 [No Abstract] [Full Text] [Related] [Next] [New Search]